Forte Biosciences Inc Share Price

NASDAQ: FBRX

Small Cap

$12.15

+0.67

(+5.84%)

as on September 17, 2025 at 1:29 am IST

$₹

Forte Biosciences Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$11.31
Day's Price Range
$12.45
$12.15
6.91%
Downside
2.47%
Upside
52 Week's Low
52 Week's High
$4.11
52-Week Price Range
$28.68
$12.15
66.17%
Downside
136.05%
Upside

Forte Biosciences Inc share price movements today

Previous Close: $11.48
Open: $11.31
Volume: 430.9K
Day's Low - High: $11.31 - $12.45
52 Week Low - High: $4.11 - $28.68

Forte Biosciences Inc Historical Returns

1 Month Return: -0.78 %
3 Month Return: -7.27 %
1 Year Return: + 61.92 %
3 Year Return: -62.97 %
5 Year Return: -99.03 %

Forte Biosciences Inc Stock Fundamentals & Key Indicators

Check Forte Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$153.3M

EPS (TTM)

-4.4325

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.69

Industry PE ratio

-4.207561643835616

P/B Ratio

PEG Ratio

EBITDA

-43.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

209231400.00%

Forte Biosciences Inc Stock Valuation

Track how Forte Biosciences Inc P/E has moved over time to understand its valuation trends.

Forte Biosciences Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Today (-4.69x)

September 17, 2025

Industry (-4.21x)

September 17, 2025

Highest (0.00x)

September 17, 2025

LowHigh

Today’s Price to Earnings Ratio: -4.69x

Forte Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Forte Biosciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Forte Biosciences Inc	BUY	$153.3M	-99.03%	-4.69	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Forte Biosciences Inc Stock including INR - Dollar returns

The Forte Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Forte Biosciences Inc investment value today

Current value as on today

₹1,76,236

Returns

₹76,236

(+76.24%)

Returns from Forte Biosciences Inc Stock

₹71,368 (+71.37%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Forte Biosciences Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Forte Biosciences Inc. Average target price of $52.25

Forte Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Forte Biosciences Inc.

What analysts predicted

76.75%UPSIDE

Target Price

$52.25

Current Price

$12.15

Analyzed by

8 Analysts

Target

$52.25

Forte Biosciences Inc target price $52.25, a slight upside of 76.75% compared to current price of $12.15. According to 8 analysts rating.

Forte Biosciences Inc Stock's Interest Amongst Investors

Search interest for Forte Biosciences Inc Stock has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:43% versus previous 30 day period

Forte Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	0	-	-	0	-	-
Gross Profit	-	-	0	0	0	0	0	0	0	0
Operating Income	-6	-9	-10	-6	-7	-12	-8	-7	-16	-11
EBITDA	-6	-9	-10	-6	-7	-12	-8	-7	-16	-11
Interest Expense	0	-	-	0	0	-	-	-	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-6	-8	-9	-5	-7	-12	-8	-7	-15	-11
Income Tax Expense	0	0	0	0	0	-	-	0	-	-
Net Income	-6	-8	-9	-5	-7	-12	-8	-7	-15	-11
Net Profit Margin	0.00%	0.00%	0.00%	-97866.67%	-123666.67%	0.00%	0.00%	-18828.95%	0.00%	0.00%

Forte Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	18	0	-	-	-	-	-
Gross Profit	0	0	0	18	0	0	0	-	0	0
Operating Income	-22	-31	-37	-45	-4	17	-21	-13	-32	-36
EBITDA	-22	-31	-36	-43	-4	-46	-21	-13	-32	-35
Interest Expense	0	1	1	0	3	-	0	0	-	-
Depreciation	-	-	-	-	0	0	0	-	0	0
Income Before Tax	-23	-33	-38	-47	-4	-46	-21	-13	-31	-35
Income Tax Expense	0	-3	-2	1	0	32	0	0	-	-35
Net Income	-23	-33	-38	-48	-4	-78	-21	-13	-31	-35
Net Profit Margin	-45207.84%	-68322.45%	-94948.78%	-271.43%	-11294.58%	0.00%	0.00%	0.00%	0.00%	0.00%

Forte Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-8	-9	-5	-7	-12	-8	-7	-15	-11
Operating Cash Flow	-5	-9	-8	-6	-5	-8	-10	-10	-10
Investing Cash Flow	-9	10	-	0	-	-	-35	36	-
Financing Cash Flow	0	24	0	0	0	0	51	-2	70
Change in Cash	-15	25	-9	-6	-5	-8	5	23	60

Forte Biosciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-33	-38	-48	-4	-46	-21	-13	-31	-35
Operating Cash Flow	-29	-31	-34	-2	-18	-16	-8	-28	-30
Investing Cash Flow	24	-27	-4	0	3	-	-	0	-35
Financing Cash Flow	2	89	43	4	66	0	7	24	51
Change in Cash	-2	30	4	1	51	-16	0	-3	-14

Global Institutional Holdings in Forte Biosciences Inc

Funds	Holdings
HHG PLC	7.53%
Fred Alger Management, LLC	7.46%
Tybourne Capital Management (HK) Ltd	5.08%
Ikarian Capital, LLC	4.99%
Bvf Inc	4.87%

See all

Insights on Forte Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, FBRX stock has moved up by 108.0%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.2% return, outperforming this stock by 6.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 174.5%

About Forte Biosciences Inc

we are driven by a vision to end cancer mortality. our company was founded on this vision in 2007. tocagen’s mission is to become a leading biopharmaceutical company for the treatment of cancer using cancer-selective gene therapy products based on our retroviral gene therapy platforms to increase lifespan, initially for patients with advanced local and metastatic cancer. our broadly applicable product candidates are designed to activate a patient’s immune system against their cancer from within. at the core of our approach is a novel gene therapy platform that utilizes retroviral replicating vectors (rrvs), which are designed to selectively deliver therapeutic genes into the dna of cancer cells. our proprietary platform is designed to fight cancer through a combination of mechanisms of action without the autoimmune toxicities that patients commonly experience with other treatments. in other words, our technology is designed to combat cancer with fewer side effects, keeping patients’ he

Organisation	Forte Biosciences Inc
Headquarters	3060 Pegasus Park Drive, Dallas, TX, United States, 75247
Industry	Health Technology
CEO	Dr. Paul A. Wagner Ph.D.
E-voting on shares	Click here to vote

Key Management of Forte Biosciences Inc

Name	Title
Dr. Paul A. Wagner Ph.D.	CEO, President & Chairman
Mr. Antony A. Riley CPA	Chief Financial Officer
Dr. Barbara K. Finck M.D.	Chief Medical Clinician & Director
Mr. Christopher Roenfeldt	Chief Operating Officer

FAQs

What is Forte Biosciences Inc share price today?

Forte Biosciences Inc share price today is $12.15 as on September 17, 2025 at 1:29 am IST at the close of the market. Forte Biosciences Inc share today touched a day high of $12.45 and a low of $11.31.

What is the 52 week high and 52 week low for Forte Biosciences Inc share?

Forte Biosciences Inc share touched a 52 week high of $28.68 on December 6, 2024 and a 52 week low of $4.11 on November 1, 2024. Forte Biosciences Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $12.15,which is 57.64% down from its 52 week high and 195.62% up from its 52 week low.

What is Forte Biosciences Inc's market capitalisation today?

Forte Biosciences Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Forte Biosciences Inc Stock (FBRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Forte Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Forte Biosciences Inc Shares that will get you 0.1235 shares as per Forte Biosciences Inc share price of $12.15 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Forte Biosciences Inc Stock (FBRX) from India?

Indian investors can start investing in Forte Biosciences Inc (FBRX) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 12:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Forte Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 12:43 pm IST). Based on Forte Biosciences Inc share’s latest price of $12.15 as on September 17, 2025 at 1:29 am IST, you will get 0.8230 shares of Forte Biosciences Inc. Learn more about fractional shares .

What are the returns that Forte Biosciences Inc has given to Indian investors in the last 5 years?

Forte Biosciences Inc stock has given -99.03% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?